Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Molecular Neurodegeneration
- Vol. 3 (1), 1
- https://doi.org/10.1186/1750-1326-3-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Aβ1–42Neuropharmacology, 2007
- Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Phospholipase A₂-Generated Lipid Mediators in the Brain: The Good, the Bad, and the UglyThe Neuroscientist, 2006
- Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 ReceptorJournal of Neuroscience, 2005
- Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nervesAmerican Journal of Physiology-Renal Physiology, 2004
- The role of platelet activating factor in prion and amyloid-β neurotoxicityNeuroReport, 2004
- Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s DiseasePharmacopsychiatry, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Influence of the Severity of Cognitive Impairment on the Effect of the Ginkgo biloba Extract EGb 761® in Alzheimer’s DiseaseNeuropsychobiology, 2002
- Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factorNeuron, 1992